The Embryo pp 227-239 | Cite as

Endometrial Proteins

  • R. Koistinen
  • M. Julkunen
  • L. Riittinen
  • A. M. Suikkari
  • M. Seppälä


Research on endometrial function and implantation has usually dealt with morphological changes in response to endocrine stimuli during the menstrual cycle, pregnancy, menopause and cancer. Biochemical events related to morphological changes have been studied during the past 10 years. Like all tissues, the endometrium contains a great number of proteins, many of which are more or less ubiquitous. Our studies have concentrated on placental and endometrial protein secretion and on the local actions of these proteins in the endometrium and elsewhere in the body. This review summarizes our studies on two proteins, namely insulin-like growth factor-binding protein (IGFBP-1) and endometrial protein PP14 (placental protein 14).


Amniotic Fluid Human Amniotic Fluid Placental Protein Secretory Endometrium Serum PP14 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alitalo T, Kontula K, Koistinen R et al. (1989) The gene encoding the human low-molecular weight insulin-like growth factor binding protein (IGF-BP25): regional localization to 7pl2-pl3 and description of a DNA polymorphism Hum Genet 83: 335–338Google Scholar
  2. Auffray C, Rougeon F (1980) Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107: 303–341PubMedCrossRefGoogle Scholar
  3. Aviv H, Leder P (1972) Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid cellulose. Proc Natl Acad Sci USA 69: 1408–1412PubMedCrossRefGoogle Scholar
  4. Barbieri RL, Hornstein MD (1988) Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect. Endocrinol Metab Clin North America 17: 685–703Google Scholar
  5. Baxter RC, Cowell CT (1987) Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 65: 432–440PubMedCrossRefGoogle Scholar
  6. Bell SC, Bohn H (1986) Immunochemical and biochemical relationship between human pregnancy-associated secreted endometrial alpha!- and alpha2-globulins (alphai- and alpha2-PEG) and the soluble placental proteins 12 and 14 (PP12 and PPM). Placenta 7: 283–294PubMedCrossRefGoogle Scholar
  7. Bell SC, Keyte JW (1988) N-terminal amino acid sequence of human pregnancy-associated endometrial alpharglobulin, an endometrial insulin-like growth factor ( IGF) binding protein - evidence for two small molecular weight IGF-binding proteins. Endocrinology 123: 1202–1204Google Scholar
  8. Bell SC, Patel S, Hales HW, Kirwan PH, Drife JO (1985) Immunochemical detection and characterization of pregnancy-associated endometrial alphar and alpha2-globulins secreted by human endometrium and decidua. J Reprod Fertil 74: 261–270PubMedCrossRefGoogle Scholar
  9. Bell SC, Keyte JW and Waites GT (1987) Pregnancy-associated endometrial alpha2-globulin, the major secretory protein of the luteal phase and first trimester pregnancy endometrium, is not glycocylated prolactin but related to B-lactoglobulins. J Clin Endocrinol Metab 65: 1067–1071PubMedCrossRefGoogle Scholar
  10. Bognar ZJ, Than GN, Csaba IF, Szabo D (1981) Placental protein 12 levels of maternal and fetal sera and amniotic fluid at delivery. IRCS Med Sci 9: 1088Google Scholar
  11. Bohn H, Kraus W (1980) Isolierung und Charakterisierung eines neuen plazentaspezifichen protein (PP12). Arch Gynecol 229: 279–291PubMedCrossRefGoogle Scholar
  12. Bohn H, Kraus W, Winckler W (1982) New soluble placental tissue proteins: their isolation, characterization, localization and quantification. In: Klopper A (ed) Immunology of human placental proteins. Praeger Publ. Placenta S4: 67–81Google Scholar
  13. Bolton AE Pockley AG, Clough KJ, et al. (1987) Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet i: 593–595Google Scholar
  14. Brewer MT, Stetler GL, Squires CH, Thompson RC, Busby WH, Clemmons DR (1988) Cloning, characterization, and expression of a human insulin-like growth factor binding protein. Biochem Biophys Res Commun 152: 1289–1297PubMedCrossRefGoogle Scholar
  15. Brinkman A, Groffen C, Kortleve DJ, van Kessel AG, Drop SLS (1988) Isolation and characterization of a cDNA encoding the low molecular weight insulin-like growth factor binding protein (IBP–1). EMBO J 7: 2417–2423PubMedGoogle Scholar
  16. Brismar K, Gutniak M, Povoa G, Werner S, Hall K (1988) Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus. J Endocrinol Invest 11: 599–602PubMedGoogle Scholar
  17. Busby WH Jr, Klapper DG, Clemmons DR (1988) Purification of a 31 000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. J Biol Chem 263: 14203–14210Google Scholar
  18. Drop SLS, Kortleve DJ, Guyda HJ (1984) Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal and adult sera. J Clin Endocrinol Metab 59: 908–915PubMedCrossRefGoogle Scholar
  19. Furlanetto RW (1980) The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab 51: 12–19PubMedCrossRefGoogle Scholar
  20. Grundmann U, Nelich C, Bohn H, Rein T (1988) Cloning of cDNA encoding human placental protein 12 (PP12): binding protein for IGF–I and somatomedin. Nucl Acids Res 16: 8711PubMedCrossRefGoogle Scholar
  21. Hall K, Hansson U, Lundin G, et al. (1986) Serum levels of somatomedins and somatomedin-binding protein in pregnant women with type I or gestational diabetes and their infants. J Clin Endocrinol Metab 63: 1300–1306PubMedCrossRefGoogle Scholar
  22. Holly JMP, Biddlecombe RA, Dunger DB, et al. (1988) Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol 29: 667–675CrossRefGoogle Scholar
  23. Hemmila I, Dakubu S, Mukkala V-M, Siitari H, Lovgren T (1984) Europium as a label in time- resolved immunofluorometric assay. Anal Biochem 137: 335–343PubMedCrossRefGoogle Scholar
  24. Howell RJS, Perry LA, Choglay NS, Bohn H, Chard T (1985) Placental protein 12 (PP12): a new test for the prediction fo the small-for-gestional-age infant. Br J Obstet Gynaecol 92: 1141–1144PubMedCrossRefGoogle Scholar
  25. Huhtala M-L, Seppala M, Narvanen A, Palomaki P, Julkunen M, Bohn H, (1987) Amino acid sequence homology between human placental protein 14 and 6–lactoglobulins from various species. Endocrinology 120: 2620–2622PubMedCrossRefGoogle Scholar
  26. Lino K, Seppala M, Heinonen PK, Sipponen P, Rutanen E-M (1986a) Elevated levels of a Somatomedin-binding protein PP12 in patients with ovarian cancer. Cancer 58: 2294–2297CrossRefGoogle Scholar
  27. Lino K, Sjoberg J, Seppala M (1986b) Elevated circulating levels of decidual protein, placental protein 12, in preeclampsia. Obstet Gynecol 68: 58–60Google Scholar
  28. Joshi SG, Bank JF, Henriques ES, Makarachi A, Matties G (1982) Serum levels of a progestagen-associated endometrial protein during the menstrual cycle and pregnancy. J Clin Endocrinol Metab 55: 642–648PubMedCrossRefGoogle Scholar
  29. Joshi SG, Rao R, Henriques EE, Raikar RS, Gordon M (1986) Luteal phase concentrations of a progestagen-associated endometrial protein ( PEP) in the serum of cycling women with adequate or inadequate endometrium. J Clin Endocrinol Metab 63: 1247–1249Google Scholar
  30. Julkunen M (1986) Human decidua synthesizes placental protein 14 (PP14) in vitro. Acta Endocrinol 112: 271–277PubMedGoogle Scholar
  31. Julkunen M, Rutanen E-M, Koskimies AI, Ranta T, Bohn H, Seppälä M (1985) Distribution of placental protein 14 in tissues and body fluids during pregnancy. Br J Obstet Gynaecol 92: 1145–1151PubMedCrossRefGoogle Scholar
  32. Julkunen M, Apter D, Seppälä M, Stenman U-H, Bohn H (1986a) Serum levels of placental protein 14 reflect ovulation in nonconceptual menstrual cycles. Fertil Steril 45: 47–50PubMedGoogle Scholar
  33. Julkunen M, Koistinen R, Sjöberg J, Rutanen E-M, Wahlströn T, Seppälä M (1986b) Secretory endometrium synthesizes placental protein 14. Endocrinology 118: 1782–1786PubMedCrossRefGoogle Scholar
  34. Julkunen M, Raikar RS, Joshi SG, Bohn H, Seppälä M (1986c) Placental protein 14 and progestogen-dependent endometrial protein are immunologically indistiguishable. Hum Reprod 1: 7–8PubMedGoogle Scholar
  35. Julkunen M, Wahlström T, Seppälä M (1986d) Human fallopian tube contains placental protein Am J Obstet Gynecol 154: 1076–1079Google Scholar
  36. Julkunen M, Koistinen R, Aalto-Setälä K, Seppälä M, Jänne OA, Kontula K (1988a) Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett 236: 295–301PubMedCrossRefGoogle Scholar
  37. Julkunen M, Seppälä M, Jänne OA (1988b) Complete amino acid sequence of human placental protein 14. A progesterone-regulated uterine protein homologous to ß-lactoglobulin. Proc Natl Acad Sei USA 85: 8845–8849Google Scholar
  38. Kiddy DS, Hamilton-Fairley D, Seppälä M, et al. (1990) Diet-induced changes in sex hormone-binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like grwoth factor I. Clin Endocrinol (in press)Google Scholar
  39. Koistinen R, Kalkkinen N, Huhtala M-L, Seppälä M, Bohn H, Rutanen E-M (1986) Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin-binding protein from human amniotic fluid. Endocrinology 118: 1375–1378PubMedCrossRefGoogle Scholar
  40. Koistinen R, Huhtala M-L, Stenman U-H, Seppälä M (1987a) Purification of placental protein PP12 from human amniotic fluid and its comparison with PP12 from placenta by immunological, physiochemical and somatomedin-binding properties. Clin Chim Acta 164: 293–303PubMedCrossRefGoogle Scholar
  41. Koistinen R, Stenman U-H, Alfthan H, Seppälä M (1987b) Time–resolved immunofluorometric assay of 34-kDa somatomedin-binding protein. Clin Chem 33: 1126–1128PubMedGoogle Scholar
  42. Lee Y-L, Hintz RL, James PM, Lee PDK, Shively JE, Powell DR (1988) Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEPG2 hepatoma cells: predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 2: 404–411PubMedCrossRefGoogle Scholar
  43. Pekonen F, Suikkari A-M, Mäkinen T, Rutanen E-M (1988) Different insulin like growth factor binding species in human placenta and decidua. J Clin Endocrinol Metab 67: 1250–1257PubMedCrossRefGoogle Scholar
  44. Petrunin DD, Gryaznova IM, Petrunina YA, Tatarinov YS (1976) Immunochemical identification of organ-specific human placental alpha2-globulin and its content in the amniotic fluid (in Russian). Byull Eksp Biol Med 82: 803–804Google Scholar
  45. Povoa G, Enberg G, Jörnvall H, Hall K (1984) Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur J Biochem 144: 199–204PubMedCrossRefGoogle Scholar
  46. Rave N, Crkvenjakov R, Boedtker H (1979) Identification of procollagen mRNAs transferred to diazobenzyloxymethyl paper from formaldehyde agarose gels. Nucl Acids Res 6: 3559–3567PubMedCrossRefGoogle Scholar
  47. Riittinen L, Stenman U-H, Alfthan H, Suikkari A-M, Bohn H, Seppälä M (1989a) Time-resolved immunofluorometric assay for placental protein 14. Clin Chim Acta 183: 115–124PubMedCrossRefGoogle Scholar
  48. Riittinen L, Julkunen M, Seppälä M, Koistinen R, Huhtala M-L (1989b) Purification and characterization of endometrial protein PP14 from midtrimester amniotic fluid. Clin Chim Acta 184: 19–30PubMedCrossRefGoogle Scholar
  49. Ritvos O, Ranta T, Jalkanen J et al. (1988) Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-1 in cultured choriocarcinoma cells. Endocrinology 122: 2150–2157PubMedCrossRefGoogle Scholar
  50. Ruoslahti E, Pierschbacher MD (1986) Arg–Gly–Asp a versatile cell recognition signal. Cell 44: 517–518PubMedCrossRefGoogle Scholar
  51. Rutanen E-M, Bohn H, Seppälä M (1982) Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 144: 460–463PubMedGoogle Scholar
  52. Rutanen E-M, Wahlström T, Koistinen R, Sipponen P, Jalanko H, Seppälä M (1984a) Placental protein 12 (PP12) in primary liver cancer and cirrhosis. Tumor Biol 5: 95–102Google Scholar
  53. Rutanen E-M, Koistinen R, Wahlstrom T, Bohn H, Ranta T, Seppala M (1985) Synthesis of placental protein 12 by human decidua. Endocrinology 116: 1304–1309PubMedCrossRefGoogle Scholar
  54. Rutanen E-M, Seppala M, Pietila R, Bohn H (1984b) Placental protein 12 (PP12): factors affecting levels in late pregnancy. Placenta 5: 243–248PubMedCrossRefGoogle Scholar
  55. Rutanen E-M, Koistinen R, Sjoberg J, et al. (1986) Synthesis of placental protein 12 by human endometrium. Endocrinology 118: 1067–1071PubMedCrossRefGoogle Scholar
  56. Seppala M, Wahlstrom T, Koskimies AI, et al. (1984) Human preovulatory follicular fluid, luteinized cells of hyperstimulated preovulatory follicles, and corpus luteum contain placental protein 12: J Clin Endocrinol Metab 58: 505–510PubMedGoogle Scholar
  57. Seppala M, Alfthan H, Vartiainen E, Stenman U-H (1987a) The postmenopausal uterus: the effect of hormone replacement therapy on the serum levels of secretory endometrial protein PP14/B-lactoglobulin homologue. Hum Reprod 2: 741–743PubMedGoogle Scholar
  58. Seppala M, Rónnberg L, Karonen S-L, Kauppila A (1987b) Micronized oral progesterone increases the circulating level of endometrial secretory PP14/6-lactoglobulin homologue. Hum Reprod 2: 453–455PubMedGoogle Scholar
  59. Seppala M, Than G (1987c) Insulin-like growth factor-binding protein PP12 in ovarian cyst fluid. Arch Gynecol Obstet 241: 33–35PubMedCrossRefGoogle Scholar
  60. Seppala M, Julkunen M, Koskimies A, Laatikainen T, Stenman U-H, Huhtala M-L (1988a) Proteins of the human endometrium: basic and clinical studies toward a blood test for endometrial function. Ann NY Acad Sci 541: 432–444PubMedCrossRefGoogle Scholar
  61. Seppala M, Riittinen L, Julkunen M, et al. (1988b) Structural studies, localization in tissue and clinical aspects of human endometrial proteins. J Reprod Fértil S 36: 127–141Google Scholar
  62. Seppala M, Martikainen H, Rónnberg L, Riittinen L, Kauppila A (1989) Suppression of prolactin secretion during ovarian hyperstimulation is followed by elevated serum levels of endometrial protein protein PP14 in the late luteal phase. Hum Reprod 4: 389–391PubMedGoogle Scholar
  63. Suikkari A-M, Rutanen E-M, Seppala M (1987) Circulating levels of immunoreactive insulin-like growth factor–binding protein in non-pregnant women. Hum Reprod 2: 297–300PubMedGoogle Scholar
  64. Suikkari A-M Koivisto VA, Rutanen E–M, Yki-Jarvinen H, Karonen S-L, Seppala M (1988) Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66: 266–272CrossRefGoogle Scholar
  65. Suikkari A-M, Jalkanen J, Koistinen R, et al. (1989a) Human granulosa cells synthesize low molecular weight insulin-like growth factor-binding protein. Endocrinology 124: 1088–1090PubMedCrossRefGoogle Scholar
  66. Suikkari A-M, Koistinen R, Yki-Járvinen H, Koivisto VA, Koskimies A, Seppala M (1989b) Association of insulin–like growth factor–binding protein (IGF–BP25) with serum insulin and reproductive functions. Proc Vancouver Meeting on IGF-binding proteins. Hintz RL (ed ), VancouverGoogle Scholar
  67. Suikkari A-M, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H (1989c) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab 68: 135–140PubMedCrossRefGoogle Scholar
  68. Suikkari A-M, Ruutiainen K, Erkkola R, Seppala M (1989d) Low levels of low molecular weight insulin-like growth factor-binding protein in patients with polycystic ovarian disease. Hum Reprod 4: 136–139PubMedGoogle Scholar
  69. Sutcliffe RG, Joshi SG, Paterson WF, Bank JF (1982) Serological identity between human uterine protein and human progestagen-dependent endometrial protein. J Reprod Fértil 65: 207–209PubMedCrossRefGoogle Scholar
  70. Than G, Seppala M, Julkunen M, et al. (1987) The effect of danazol on the circulating levels of 34K insulin-like growth factor-binding protein (PP12) and endometrial secretory protein PP14. Hum Reprod 2: 549–551PubMedGoogle Scholar
  71. Telimaa S, Kauppila A, Rónnberg L, Seppala M (1989) Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis: suppression by treatment with danazol and high dose medroxyprogesterone acetate. Am J Obstet Gynecol 161: 866–871PubMedGoogle Scholar
  72. Wahlstrom T, Seppala M (1984) Placental protein 12 (PP12) is induced in the endometrium by progesterone. Fértil Steril 41: 781–784PubMedGoogle Scholar
  73. Wahlstrom T, Huhtaniemi I, Hovatta O, Seppala M (1983) Localization of luteinizing hormone, follicle-stimulating hormone, prolactin and their receptors in the human and rat testis using immunohistochemistry and radioreceptor assay. J Clin Endocrinol Metab 57: 825–830PubMedCrossRefGoogle Scholar
  74. Waites GT, James RFL, Bell SC (1988) Immunohistological localization of the human endometrial secretory protein pregnancy-associated endometrial alpharglobulin, an insulin-like growth factor-binding protein, during the menstrual cycle. J Clin Endocrinol Metab 67: 1100–1104PubMedCrossRefGoogle Scholar
  75. Westwood OMR, Chapman MG, Totty N, Philip R, Bolton AE, Lazarus NR (1988) N-terminal sequence analysis of human placental protein 14, purified in high yield from decidual cytosol. J Reprod Fertil 82: 493–500PubMedCrossRefGoogle Scholar
  76. Wood WI, Cachianes G, Henzel WJ, et al. (1988) Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 2: 1176–1185PubMedCrossRefGoogle Scholar
  77. Yee D, Favoni RE, Lupu R, et al. (1989) The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells. Biochem Biophys Res Commun 158: 38–44PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 1991

Authors and Affiliations

  • R. Koistinen
  • M. Julkunen
  • L. Riittinen
  • A. M. Suikkari
  • M. Seppälä

There are no affiliations available

Personalised recommendations